You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 3, September 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

20, 25-Diazacholestenol Dihydrochloride

Inhibition of Cholesterol Biosynthesis in Hyperlipemic Subjects

BERNARD A. SACHS, MD; LILA WOLFMAN, BA

Arch Intern Med. 1965;116(3):366-372.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE QUEST for the ideal inhibitor of cholesterol biosynthesis continues. To date, the clinical use of such inhibitors has disclosed definite disadvantages which include the accumulation in serum of triglycerides 1 or a precursor sterol, 24-dehydrocholesterol (desmosterol).2,3 The theoretically ideal inhibitor would be free of these disadvantages and would have its specific site of inhibition between β-hydroxy-β-methyl-glutaryl CoA and mevalonic acid. This has been suggested as the inhibition point in the negative feedback control of cholesterol synthesis by dietary cholesterol.4 The synthetic structural analog of cholesterol, 20,25-diazacholestenol dihydrochloride (SC-12937; 20,25-diazacholesterol) (Fig 1), was found to have its primary site of action at this enzymatic step and produced marked falls in serum cholesterol levels in experimental animals.5 Therefore, the compound was administered over a prolonged period of time to 13 patients with severe disorders of lipid metabolism and their serum lipids were studied.

Materials and Methods

The subjects . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the Endocrine Service, Medical Division, Mantefiore Hospital and Medical Center. Head, Endocrine Service (Dr. Sachs) and Research Assistant (Miss Wolfman).


Footnotes

Received for publication Dec 2, 1964; accepted Jan 27, 1965.

Reprint requests to Montefiore Hospital and Medical Center, 210th St and Bainbridge Ave, New York 67, NY (Dr. Sachs).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.